Kava-containing Biolife FX products should not be used, FDA warns.
This article was originally published in The Tan Sheet
Executive Summary
FDA WARNING ON KAVA-CONTAINING BIOLIFE FX PRODUCTS issued following approximately 50 reports of adverse reactions experienced by New Year's Eve revelers attending a Los Angeles, Calif. concert at which the supplement product was distributed. FDA said Jan. 1 that it has "advised consumers not to consume colored liquid products labeled Orange FX Crush, Lemon FX Drop and Cherry FX Bomb."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning